https://www.selleckchem.com/pr....oducts/740-y-p-pdgfr
Results The intervention group benefits from a lower global encrustation rate of stent ends than placebo group (1% vs 8.2%; p less then 0.018). Mean encrustation score was 85.12 (274.5) in the placebo group and 18.91 (102.27) in the intervention group (p less then 0.025). Considering the secondary end points, treated patients reported greater urine pH decreases (p = 0.002). No differences in the incidence of adverse events were identified between the groups. Conclusions Our data suggest that the use of this new oral composi
Like
Comment
Share
